The relationship between apolipoprotein E, dementia, and vascular illness

Atherosclerosis

Volumn 140, Issue 1, 1998, Pages 173-180

  Marin, Deborah B ^a   Breuer, Brenda ^b   Marin, Michael L ^a   Silverman, Jeremy ^a   Schmeidler, James ^a   Greenberg, David ^a   Flynn, Sean ^a   Mare, Marlene ^a   Lantz, Melinda ^b   Libow, Leslie ^b   Neufeld, Richard ^b   Altstiel, Lawrence ^c   Davis, Kenneth L ^a   Mohs, Richard C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Jewish Home and Hospital   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Aged; Apolipoprotein; Dementia; Vascular illness

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

AGED; AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; STROKE;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BRAIN ISCHEMIA; DEMENTIA, VASCULAR; FEMALE; FRAIL ELDERLY; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; MALE;

EID: 0032171459     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00105-1     Document Type: Article

References (54)

1. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W.et al. Gene dose of apolipoprotein E type 4 and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
2. Mayeux R., Stern Y., Ottman R., Tatemichi T.K., Tang M., Maestre G.et al. The apolipoprotein ε4 allele in patients with Alzheimer's disease. Ann Neurol. 34:1993;752-754.
3. Rebeck G.W., Reiter J.S., Strickland D.K., Hyman B.T. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron. 11:1993;575-580.
4. Saunders A.M., Strittmatter W.J., Schmechel D., St. George-Hyslop P.H., Pericak-Vance M.A., Joo S.H.et al. Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467.
5. Strittmatter W.J., Saunders A.M., Alberts M.J.et al. Apolipoprotein E: high-avidity binding to B-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA. 90:1993;1977-1981.
6. Tsai M.S., Tangalos E.G., Petersen R.C., Smith G.E., Schaid D.J., Kokmen E.et al. Apolipoprotein E: risk factor for Alzheimer's disease. Am J Hum Genet. 54:1994;643-649.
7. Gomez-Isla T., West H.L., Rebeck W., Harr S.D., Growdon J.H., Locascio J.J.et al. Clinical and pathological correlates of apolipoprotein ε4 in Alzheimer's disease. Ann Neurol. 39:1996;62-70.
8. Myers R.H., Schaefer E.J., Wilson P.W., D'Agostino R., Ordovas J.M., Espino A.et al. Apolipoprotein E epsilon 4 association with dementia in a population-based study: The Framingham study. Neurology. 46:1996;673-677.
9. Greiner L.H., Snowdon D.A. Brain infarction and the clinical expression of Alzheimer's disease. J Am Med Assoc. 277:1997;813-817.
10. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.
11. Kuusi T., Nieminen M.S., Ehnholm C., Yki-Jarvinen H., Valle M., Nikkila E.A.et al. Apolipoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis. 9:1989;237-241.
12. Van Bockmeer F.M., Mamotte C.D.S. Apolipoprotein E4 homozygosity in young men with coronary heart disease. Lancet. 340:1992;879-880.
13. Eichner J.E., Kuller L.H., Orchard T.J., Grandits G.A., McCallum L.M., Ferrell R.E.et al. Relation of apolipoprotein E phenotype to myocardial infarction infarction and mortality from coronary artery disease. Am J Cardiol. 71:1993;160-165.
14. Pedro-Botet J., Senti M., Nogues X., Rubies-Prat J., Roquer J., D'Olhaberriague L., Olive J. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Stroke. 23:1992;1556-1562.
15. Couderc R., Mary F., Bailleul S., Fenelon G., Mary R., Fermanian J. Prevalence of apolipoprotein phenotypes in ischemic cerebrovascular disease. A case control study. Stroke. 24:1993;661-664.
16. Alberts M.J., Graffagnino C., McClenny C., Delong D., Strittmatter W., Saunders A.M., Roses A.D. Apo E genotype and survival from intracerebral haemorrhage [letter]. Lancet. 346:1995;575.
17. Betard C., Robitaille Y., Gee M., Tiberghien D., Larrivee D., Roy P.et al. Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia. Neuroreport. 5:1994;1893-1896.
18. Shimano H., Ishibashi S., Murase T., Gotohda T., Yamada N., Takaku F.et al. Plasma apolipoprotein in patients with multi-infarct dementia. Atherosclerosis. 79:1989;257-260.
19. Tomimoto H., Akiguchi I., Suenaga T., Wakita H., Nakamura S., Kimura J.et al. Immunohistochemical study of apolipoprotein E in human cerebrovascular white matter lesions. Acta Neuropathol (Berl). 90:1995;608-614.
20. Blacker D., Haines J.L., Rodes L., Terwedow H., Go R.C., Harrell L.E.et al. Apo E-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology. 48:1997;139-147.
21. Altstiel L.D., Greenberg D., Marin D.B., Lantz M., Mohs R. Apolipoprotein E genotype and cognition in the very old. Lancet. 349:1997;1451.
22. Folstein M.F., Folstein S.E., McHugh P.R. The Mini Mental State Exam. J Psychiatr Res. 12:1975;187-198.
23. ICD 9 CM. International Classification of Diseases, 9th revision. New York: PMIC, 1994.
24. The Diagnostic and Statistical Manual, 4th ed., Washington: APA Press, 1994.
25. Hixson J.E. P-Day Research group. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Arterioscler Thromb. 11:1991;1237-1244.
26. Saunders A.M., Roses A.D. Apolipoprotein E4 allele frequency, ischemic cerebrovascular disease, and Alzheimer's disease. Stroke. 24:1993;1416.
27. Jarvick G.P., Wijsman E.M., Kukull W.A., Schellenberg G.D., Yu C., Larson E. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease. Neurology. 45:1995;1092-1096.
28. Frisoni G.B., Calabresi L., Geroldi C., Bianchetti A., Granceschini G., Trabucchi M. Gene dose of the ε4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol. 37:1995;596-604.
29. Houlden H., Crook R., Duff K., Hutton M., Collinge J., Roques P.et al. Apolipoprotein E alleles but neither apolipoprotein B nor apoliprotein AI/CIII alleles are associated with late onset, familial Alzheimer's disease. Neurosci Lett. 188:1995;202-204.
30. Yu C., Payami H., Olson J.M., Boehnke M., Wijsman E.M., Orr H.T.et al. The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer's disease. Am J Hum Genet. 54:1994;631-642.
31. Drachman D. If we live long enough, will we all be demented? Neurology. 44:1994;1563-1565.
32. Kawamata J., Tanaka S., Shimohama S., Kimura J. Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J Neurol Neurosurg Psychiatry. 57:1994;1414-1416.
33. Asada T., Yamagata Z., Kinoshita T., Kinoshita A., Kariya T., Asaka A.et al. Prevalence of dementia and distribution of ApoE alleles in Japanese centenarians: an almost-complete survey in Yamanashi Prefecture, Japan. J Am Geriatr Soc. 44:1996;151-155.
34. Polvikoski T., Sulkava R., Haltia M., Kainulainen K., Vuorio A., Verkkoniemi A.et al. Apolipoprotein E, dementia, and cortical deposition of B-Amyloid protein. New Engl J Med. 333:1995;1242-1247.
35. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D., Gaskell P.C., Rimmler J.B.et al. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology. 45:1995;1323-1328.
36. Slooter A.J.C., Tang M., Dujin C.M., Stern Y., Ott A., Bell K.et al. Apolipoprotein E ε4 and the risk of dementia with stroke. A population-based investigation. J Am Med Assoc. 277:1997;818-821.
37. Noguchi S., Murakami K., Yamada N. Apolipoprotein E genotype and Alzheimer's disease. Neurosci Lett. 342:1993;737.
38. Treves T.A., Bornstein N.M., Chapman J., Klimovitzki S., Verchovsky A., Asherov A.et al. APOE-ε4 in patients with Alzheimer's disease and vascular dementia. Alzheimer's Dis Assoc Dis. 1996:1996;189-191.
39. Isoe K., Urakami K., Sato K., Takahashi K. Apolipoprotein E in patients with dementia of the Alzheimer's type and vascular dementia. Acta Neurol Scand. 93:1996;133-137.
40. Hofman A., Ott A., Breteler M.M.B., Bots M.L., Slooter A.J.C., Harskamp F.et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet. 349:1997;151-154.
41. Wieringa G.E., Burlinson S., Rafferty J.A., Gowland E., Burns A. Apoliprotein E genotypes and serum lipid levels in Alzheimer's disease and multi-infarct dementia. Int J Geriatr Psychiatry. 12:1997;359-362.
42. Scacchi R., De Bernardini L., Mantuano E., Donini L.M., Vilardo T., Corbo R.M. Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer's disease (AD), mixed dementia and vascular dementia: lack of association of epsilon 4 allele with AD in Italian octogenarian patients. Neurosci Lett. 201:1995;231-234.
43. Stengard J.H., Pekkanen J., Sulkava R., Ehnholm C., Erkinjuntti T., Nissinen A. Apolipoprotein E polymorphism, Alzheimer's disease and vascular dementia among elderly Finnish men. Acta Neurol Scand. 92:1995;297-298.
44. Higuchi S., Arai H., Nakagawa T., Muramatsu T., Sasaki T., Trojanowski J.Q. The apolipoprotein E gene in Binsanger's disease and vascular dementia. Clin Genet. 50:1996;459-461.
45. Feskens E.J.M., Havekes L., Kalmijn S., Knijff P.D., Launer L.J., Kromhout D. Apolipoprotein E4 allele and cognitive decline in elderly men. Br Med J. 309:1994;1202-1206.
46. Wolf P.A., D'Agostino R., Belanger A.J., Kannel W.B. Probability of stroke: a risk profile from the Framingham study. Stroke. 22:1991;312-318.
47. Meyer J.S., McClintic K.L., Rogers R.L., Sims P., Mortel K.F. Aetiological considerations and risk factors for multi-infarct dementia. J Neurol Neurosurg Psychiatry. 51:1988;1489-1497.
48. Mortel K.F., Wood S., Pavol M.A., Meyer J.S., Rexer J.L. Analysis of familial and individual risk factors among patients with ischemic vascular dementia and Alzheimer's disease. Angiology. 1:1993;599-605.
49. Skoog I., Nilsson L., Palmertz B., Andreasson L.A., Svanborg A. A population-based study of dementia in 85-year-olds. New Engl J Med. 328:1992;153-158.
50. Mizutani T., Shimada H. Neuropathological background of twenty-seven centenarian brains. J Neurol Sci. 108:1992;168-177.
51. Chui H.C., Victoroff J.I., Margolin D., Jagust W., Shankle R., Katzman R. Criteria for diagnosis of ischemic vascular dementia proposed by the state of California disease diagnostic and treatment centers. Neurology. 42:1992;473-480.
52. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadler E.M. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzeimer's disease. Neurology. 34:1984;934-944.
53. Roman G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Gracia J.H.et al. Vascular dementia: diagnostic criteria for research studies: report of the NINCDS-AIREN International Workshop. Neurology. 43:1993;250-260.
54. Thal L., Grundman M., Klauber M.R. Dementia: characteristics of a referral population and factors associated with progression. Neurology. 38:1988;1083-1090.